Latest 10-K annual reports

ZW Data Action Technologies Inc. reported a significant revenue decline in 2025 to $4.61 million from $15.44 million in 2024, alongside a reduced net loss, as it strategically shifts focus to higher-margin digital advertising and AI/blockchain services outside mainland China.

Xtant Medical Holdings, Inc. achieved net income in 2025 driven by license revenue and orthobiologics sales, despite divesting Coflex/CoFix assets and international hardware business, which will impact 2026 revenues.

NexPoint Diversified Real Estate Trust reported a substantial net loss of $127 million in 2025, driven by mark-to-market losses on investments, while actively pursuing strategic asset reallocation and capital raises.

Charlotte's Web Holdings reports mixed 2025 results, showing slight revenue growth and reduced operating losses, driven by product diversification and cost-cutting, while facing significant regulatory uncertainty and a substantial capital raise from BAT.

Thunder Mountain Gold, an exploration-stage company, reported a net loss of $2.83 million for fiscal year 2025, while advancing its South Mountain Project with increased mineral resources and strategic partnerships.

VerifyMe, Inc. reports a 32% revenue drop and increased net loss for 2025, driven by a key carrier partnership loss and significant impairment charges, while pursuing a highly dilutive merger with Open World Ltd.

BlockchAIn Digital Infrastructure, Inc. completed a business combination, shifted its focus to AI/HPC, and reported a net loss of $0.8 million for 2025, down from a $5.7 million net income in 2024.

Meridian Holdings grew FY2025 revenue 21% to $182.9M but booked $91.8M of non‑cash impairments, swinging to a $92.0M net loss and ending the year with a $24.1M working capital deficit.

First Foundation Inc. filed an amended annual report for 2025, detailing corporate governance, executive compensation, and revealing a significant net loss and negative return on equity.

Allbirds, Inc. reported significant net losses and revenue decline for fiscal year 2025, raising substantial doubt about its ability to continue as a going concern, and announced a definitive agreement to sell substantially all assets.

Solana Company, formerly Helius Medical Technologies, Inc., has strategically shifted its focus to a digital asset treasury centered on Solana tokens, reporting a net loss of $40.9 million for 2025 amidst significant market volatility.

Laird Superfood, Inc. reports increased net sales for FY2025, driven by wholesale growth, alongside a strategic acquisition of Navitas Organics and a $50 million investment from Nexus Capital Management LP.

Haymaker Acquisition Corp. 4 reported a net loss for 2025 while progressing towards its business combination with Suncrete, extending its deadline to July 2026.

TherapeuticsMD reports reduced net loss and increased license revenue in 2025, but faces substantial doubt about its going concern status due to ongoing legal disputes and liquidity challenges.

DeFi Development Corp. shifted its primary strategy in 2025 to focus on the Solana blockchain ecosystem, reporting a substantial net loss of $73.8 million for the year.

BGSF, Inc. reported substantial net losses from continuing operations for fiscal year 2025, alongside a strategic divestiture of its Professional segment and a special cash dividend.

Peraso Inc. reported a significantly reduced net loss of $4.8 million in 2025, driven by a shift to mmWave products and ongoing strategic review discussions, despite a decline in overall revenue and persistent going concern doubt.

Curanex Pharmaceuticals Inc. completed its IPO, raised $15.3 million, and is progressing its lead botanical drug candidate, Phyto-N, into clinical development for inflammatory diseases, despite reporting a $4.2 million net loss and internal control weaknesses.

SoundThinking, Inc. reported a 2% increase in revenues to $104.1 million for fiscal year 2025, alongside a net loss of $9.4 million, driven by new customer acquisitions and expansions, but impacted by the non-renewal of a major contract with the City of Chicago.

zSpace, Inc. reported a 27% revenue decrease in 2025, ongoing net losses, and significant doubt about its ability to continue as a going concern, despite recent capital raises.

Live Oak Acquisition Corp. V's annual report details its planned merger with Teamshares Inc. while disclosing a net loss and substantial doubt about its ability to continue as a going concern.

WinVest Acquisition Corp. reports significant redemptions, Nasdaq delisting, and substantial doubt about its ability to continue as a going concern, despite pursuing a new business combination.

Bio Green Med Solution, formerly Cyclacel Pharmaceuticals, Inc., completed a strategic pivot in 2025, divesting its pharmaceutical assets and acquiring a Malaysian fire safety business, Fitters Sdn. Bhd., while facing ongoing financial challenges and a preferred stock delisting.

American Eagle Outfitters reports mixed Fiscal 2025 results with Aerie driving revenue growth amid increased tariffs and significant impairment charges, while American Eagle brand sales remained flat.

Siebert Financial Corp. reported a significant decrease in net income to $5.1 million in 2025 from $13.3 million in 2024, despite a 12.3% increase in net revenues, driven by strategic expansions and technology investments.

The LGL Group, Inc. reported a 59.3% increase in net income attributable to common stockholders for 2025, primarily driven by a significant income tax benefit, despite a decline in total revenues and operational income.

Pathfinder Bancorp, Inc. reported a net loss of $1.9 million for the full year 2025, primarily driven by a significant increase in provision for credit losses and fair value adjustments on loans held-for-sale.

Pyrophyte Acquisition Corp. II, a blank check company, reported net income of $2.97 million for 2025 while actively searching for an initial business combination in the energy sector.

Camber Energy reported a significantly reduced net loss for 2025, driven by a gain on subsidiary disposal, but continues to face substantial doubt about its ability to continue as a going concern amidst operational challenges and material weaknesses in internal controls.

Glucotrack, Inc. reports progress on its implantable continuous blood glucose monitor and recent financing, but faces substantial doubt about its ability to continue as a going concern and ongoing Nasdaq listing challenges.